Related Experiment Videos
Octreotide and diabetes: theoretical and experimental aspects
H Orskov1, A Flyvbjerg, J Frystyk
1Institute of Experimental Clinical Research, Aarhus Kommunehospital, Denmark.
Metabolism: Clinical and Experimental
|September 1, 1992
Summary
Diabetes involves high growth hormone and glucagon levels, worsening metabolic control. Octreotide may help reduce these hormonal issues and related diabetic complications, as shown in experimental trials.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Mellitus Research
Background:
- Diabetes is marked by high growth hormone (hypersomatotropinemia) and glucagon (hyperglucagonemia).
- These hormonal imbalances negatively impact nitrogen balance, carbohydrate and lipid metabolism, and insulin sensitivity.
- Hypersomatotropinemia is linked to functional abnormalities contributing to diabetic complications.
Purpose of the Study:
- To investigate the potential of octreotide in mitigating diabetes-associated hormonal aberrations.
- To evaluate octreotide's effect on functional abnormalities linked to diabetic complications.
Main Methods:
- The study discusses theoretical actions of octreotide based on its known effects.
- Experimental trials were conducted to confirm these theoretical benefits.
Main Results:
- Octreotide's actions are theorized to reduce metabolic aberrations.
- Experimental data confirmed that octreotide can reduce these aberrations.
Conclusions:
- Octreotide shows promise in managing hormonal dysregulation in diabetes.
- This suggests a potential therapeutic role for octreotide in reducing diabetic complications.